Stocklytics Platform
Asset logo for symbol ALT
Altimmune
ALT69
$6.37arrow_drop_up2.40%$0.14
Asset logo for symbol ALT
ALT69

$6.37

arrow_drop_up2.40%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Altimmune (ALT) Stocklytics Forecast

Altimmune Inc (ALT) is a biopharmaceutical company that focuses on developing and commercializing innovative products for the treatment of infectious diseases. The company's stock price has shown promising growth in recent years, and many analysts believe that this positive trend will continue in the future. According to machine learning predictions, ALT stock is expected to experience further growth in the coming years. The stock price forecast for ALT in 2023 indicates a significant increase compared to its current value. Analysts have also set a price target for the stock in 2023, further supporting the positive outlook for ALT. With these forecasts and analyst ratings, it is evident that ALT stock is considered a good buy by many investors.
Altimmune Inc has been gaining recognition in the biopharmaceutical industry for its development of innovative and effective treatments for infectious diseases. The company has a strong pipeline of products in various stages of development, which has contributed to its positive stock performance. Analysts have been closely monitoring ALT and have provided optimistic price targets for the stock. These price targets suggest that the stock has the potential for significant growth in the next few years. Additionally, ALT has received positive analyst ratings, further reinforcing the notion that the stock is a good buy. With the combination of positive forecasts, analyst ratings, and the company's track record of success, ALT is an attractive investment option for those interested in the biopharmaceutical sector.
add Altimmune  to watchlist

Keep an eye on Altimmune

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Altimmune (ALT) stock?

Analysts have set a target price of $23.96 for Altimmune (ALT), based on forecasts from 28 analysts. The predicted price range extends from a high of $50 to a low of $6. This represents a potential increase of up to 684.93% and a decrease of -5.81% from the current price of $6.37. These forecasts are as of 2021 Jun 30.
help

What are the analyst ratings for Altimmune (ALT) stock?

Currently, there are no analyst ratings available for Altimmune (ALT), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Altimmune (ALT) stock?

At present, there is no AI or machine-learning-based price prediction available for Altimmune (ALT) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level